Specify a stock or a cryptocurrency in the search bar to get a summary
Hisamitsu Pharmaceutical Inc
HPXHisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Address: Tashirodaikan-machi 408, Tosu, Japan, 841-0017
Analytics
WallStreet Target Price
619 113.53 JPYP/E ratio
20.6611Dividend Yield
2.15 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures HPX
Dividend Analytics HPX
Dividend growth over 5 years
-48 %Continuous growth
2 yearsPayout Ratio 5 years average
45 %Dividend History HPX
Stock Valuation HPX
Financials HPX
Results | 2019 | Dynamics |